170 related articles for article (PubMed ID: 23307241)
1. Survival difference in NSCLC and SCLC patients with diabetes mellitus according to the first-line therapy.
Nakazawa K; Kurishima K; Tamura T; Ishikawa H; Satoh H; Hizawa N
Med Oncol; 2013 Mar; 30(1):367. PubMed ID: 23307241
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies.
Zhu L; Cao H; Zhang T; Shen H; Dong W; Wang L; Du J
Medicine (Baltimore); 2016 Apr; 95(17):e3528. PubMed ID: 27124062
[TBL] [Abstract][Full Text] [Related]
3. [A retrospective study of the impact of diabetes mellitus on survival in patients with lung cancer].
Han R; Yang G; Lyu Z; Gu W; Du J; Jin N; Zang L; Yang L; Guo Q; Ba J; Dou J; Mu Y
Zhonghua Nei Ke Za Zhi; 2015 Dec; 54(12):1028-31. PubMed ID: 26887369
[TBL] [Abstract][Full Text] [Related]
4. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin in the prognosis of patients with smallcell lung cancer combined with diabetes mellitus.
Lu H; Xie F; Huang Z; Qin J; Han N; Mao W
Adv Clin Exp Med; 2018 Sep; 27(9):1195-1199. PubMed ID: 30016011
[TBL] [Abstract][Full Text] [Related]
6. Is diabetes mellitus a prognostic factor for survival in patients with small cell lung cancer?
Inal A; Kaplan MA; Kucukoner M; Urakci Z; Karakus A; Nas N; Guven M; Isikdogan A
Asian Pac J Cancer Prev; 2012; 13(4):1491-4. PubMed ID: 22799354
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009.
Lüchtenborg M; Riaz SP; Lim E; Page R; Baldwin DR; Jakobsen E; Vedsted P; Lind M; Peake MD; Mellemgaard A; Spicer J; Lang-Lazdunski L; Møller H
Thorax; 2014 Mar; 69(3):269-73. PubMed ID: 24172710
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer?
Sun JM; Ahn MJ; Ahn JS; Um SW; Kim H; Kim HK; Choi YS; Han J; Kim J; Kwon OJ; Shim YM; Park K
Lung Cancer; 2012 Aug; 77(2):365-70. PubMed ID: 22579297
[TBL] [Abstract][Full Text] [Related]
9. Effect of diabetes mellitus on the outcome of patients with resected non-small cell lung carcinoma.
Bartling B; Simm A; Sohst A; Silber RE; Hofmann HS
Gerontology; 2011; 57(6):497-501. PubMed ID: 21411967
[TBL] [Abstract][Full Text] [Related]
10. Poor glycemic control might compromise the efficacy of chemotherapy in non-small cell lung cancer patients with diabetes mellitus.
Zeng X; Xu C; Cheng J; Sun C; Wang Z; Gong Z; Long H; Zhu B
Cancer Med; 2020 Feb; 9(3):902-911. PubMed ID: 31830375
[TBL] [Abstract][Full Text] [Related]
11. Gamma knife radiosurgery for metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma.
Serizawa T; Ono J; Iichi T; Matsuda S; Sato M; Odaki M; Hirai S; Osato K; Saeki N; Yamaura A
J Neurosurg; 2002 Dec; 97(5 Suppl):484-8. PubMed ID: 12507082
[TBL] [Abstract][Full Text] [Related]
12. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
[TBL] [Abstract][Full Text] [Related]
13. The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer.
Miura Y; Imai H; Sakurai R; Kaira K; Sunaga N; Minato K; Saito R; Hisada T
Med Oncol; 2018 Mar; 35(4):45. PubMed ID: 29508094
[TBL] [Abstract][Full Text] [Related]
14. KMT2D Mutation Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer.
Ardeshir-Larijani F; Bhateja P; Lipka MB; Sharma N; Fu P; Dowlati A
Clin Lung Cancer; 2018 Jul; 19(4):e489-e501. PubMed ID: 29627316
[TBL] [Abstract][Full Text] [Related]
15. Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.
Shaw GL; Gazdar AF; Phelps R; Steinberg SM; Linnoila RI; Johnson BE; Oie HK; Russell EK; Ghosh BC; Pass HI; Minna JD; Mulshine JL; Ihde DC
J Cell Biochem Suppl; 1996; 24():173-85. PubMed ID: 8806100
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide-based chemotherapy for previously treated lung cancer patients.
Chen YM; Liu JM; Wu MF; Wu HW; Lin WC; Tsai CM; Perng RP; Whang-Peng J
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391
[TBL] [Abstract][Full Text] [Related]
17. Current standards of care in small-cell and non-small-cell lung cancer.
Schiller JH
Oncology; 2001; 61 Suppl 1():3-13. PubMed ID: 11598409
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
[TBL] [Abstract][Full Text] [Related]
19. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
[TBL] [Abstract][Full Text] [Related]
20. A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patients.
Mo H; Hao X; Liu Y; Wang L; Hu X; Xu J; Yang S; Xing P; Shi Y; Jia B; Wang Y; Li J; Wang H; Wang Z; Sun Y; Shi Y
Cancer Med; 2016 Jun; 5(6):1116-24. PubMed ID: 26993156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
